Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia

This publication has 58 references indexed in Scilit:

• Administration of a Sigma Receptor Agonist Delays MCAO-Induced Neurodegeneration and White Matter Injury
  Translational Stroke Research, 2010
• Ac-YVAD-CMK Decreases Blood–Brain Barrier Degradation by Inhibiting Caspase-1 Activation of Interleukin-1β in Intracerebral Hemorrhage Mouse Model
  Translational Stroke Research, 2009
• Erythropoietin protects post-ischemic hearts by preventing extracellular matrix degradation: Role of Jak2-ERK pathway
  Life Sciences, 2007
• Matrix Metalloproteinase 2 (MMP2) and MMP9 Secreted by Erythropoietin-Activated Endothelial Cells Promote Neural Progenitor Cell Migration
  The Journal of Neuroscience, 2006
• Neonatal Hypoxia/Ischemia Is Associated With Decreased Inflammatory Mediators After Erythropoietin Administration
  Stroke, 2005
• Erythropoietin protects from axotomy‐induced degeneration of retinal ganglion cells by activating ERK‐1/‐2
  The FASEB Journal, 2004
• Hypoxia-Induced Stroke Tolerance in the Mouse Is Mediated by Erythropoietin
  Stroke, 2003
• Complex roles of tissue inhibitors of metalloproteinases in cancer
  Oncogene, 2002
• The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction
  Trends in Endocrinology & Metabolism, 1999
• JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin
  Cell, 1993